Clinical value of FDG PET/CT in screening for distant metastases in head and neck squamous cell carcinoma

S E Deurvorst, O S Hoekstra, J A Castelijns, B I Witte, C R Leemans, R de Bree

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

OBJECTIVES: The detection of distant metastases is of major importance in management of head and neck squamous cell carcinoma patients.

DESIGN: All patients underwent 18 FDG PET/CT for the detection of distant metastases.

SETTING: Retrospective single-centre study.

PARTICIPANTS: Head and neck squamous cell carcinoma patients with high-risk factors for distant metastases.

MAIN OUTCOME MEASURES: Accuracy of 18 FDG PET/CT for the detection of distant metastases using clinical development of distant metastases and a minimal follow-up of twelve months as reference standard. Comparison of overall survival between patients diagnosed with distant metastases during initial screening and patients diagnosed with distant metastases during follow-up.

RESULTS: In 23 (12%) of the 190 patients, 18 FDG PET/CT detected distant metastases at screening. Sensitivity and negative predictive value were 46.2% (95% CI 32.6-59.7) and 82.6% (95% CI 76.8-88.5). No difference in median overall survival from the time of distant metastases detection was found between patients diagnosed with DM during work-up or during follow-up.

CONCLUSIONS: In head and neck squamous cell carcinoma patients with high-risk factors, 18 FDG PET/CT has a high negative predictive value for the detection of distant metastases and should be used in daily clinical practice, although the sensitivity is limited when long-term follow-up is used as reference standard.

Original languageEnglish
Pages (from-to)875-881
Number of pages7
JournalClinical Otolaryngology
Volume43
Issue number3
DOIs
Publication statusPublished - Jun 2018

Cite this